Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) today announced the pricing of its initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share....
-
Miami Beach, FL, March 31, 2026 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. VI (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, share...
-
New York City, March 29, 2026 (GLOBE NEWSWIRE) -- The newly formed firm and group are announcing their intention to raise initial bridge financing through offerings under the U.S. SEC’s Regulation D...
-
Miami Beach, FL , March 27, 2026 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. VI (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, share...
-
SALT LAKE CITY, March 26, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates...
-
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Middlefield, on behalf of MRF 2026 Resource Limited Partnership (“MRF 2026” or the “Partnership”), is pleased to announce that it has completed the second...
-
WUXI, China, March 23, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative electric vehicles manufacturer and seller, today announced that it has...
-
ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...
-
HOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) today announced that it has launched the initial public offering of 10,520,000 shares of its Class A common stock. The...
-
CUPERTINO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that...